Table 2.
Complications
| All Patients | Overall (n=1,285)1 | Commercial (n=1,011)1 | Medicaid (n=89)1 | Medicare (n=185)1 | p-value2 |
|---|---|---|---|---|---|
| Abdominal wall - hernia | 8 (0.6%) | 6 (0.6%) | 0 (0%) | 2 (1.1%) | 0.6 |
| Infection/cellulitis | 174 (14%) | 128 (13%) | 16 (18%) | 30 (16%) | 0.2 |
| Delayed healing | 63 (4.9%) | 49 (4.8%) | 2 (2.2%) | 12 (6.5%) | 0.3 |
| Mastectomy Skin Flap/Nipple Necrosis | 175 (14%) | 134 (13%) | 9 (10%) | 32 (17%) | 0.2 |
| Total Flap Loss | 15 (1.2%) | 8 (0.8%) | 4 (4.5%) | 3 (1.6%) | 0.014 |
| Seroma | 58 (4.5%) | 52 (5.1%) | 3 (3.4%) | 3 (1.6%) | 0.085 |
| Wound Dehiscence | 59 (4.6%) | 53 (5.2%) | 4 (4.5%) | 2 (1.1%) | 0.026 |
| Hematoma | 94 (7.3%) | 70 (6.9%) | 5 (5.6%) | 19 (10%) | 0.2 |
| Systemic Comorbidities (DVT, PE, pneumonia) | 12 (0.9%) | 8 (0.8%) | 1 (1.1%) | 3 (1.6%) | 0.4 |
| Any Complication | 655 (51%) | 509 (50%) | 47 (53%) | 99 (54%) | 0.7 |
| Readmission within 90 days | 138 (11%) | 100 (9.9%) | 14 (16%) | 24 (13%) | 0.13 |
| Reoperation within 90 days | 558 (43%) | 440 (44%) | 45 (51%) | 73 (39%) | 0.2 |
1
n (%),
2
Kruskal-Wallis rank sum test; Fisher’s exact test; Pearson’s Chi-squared test